I work closely with my patients who are on acid-blocking medication to find the source of the issue, which is often related to diet and lifestyle or mast cell activation from exposure to medications, toxins, or infection
For every 100 people who start retatrutide, somewhere between 12 and 18 will find the side effects intolerable enough to stop
None of GHK-Cu, BPC-157, or TB-500 has an approved human indication, and the GLOW combination specifically has no clinical trial establishing safety or efficacy in humans
Research demonstrates that 5-Amino-1MQ exhibits high selectivity for NNMT and does not inhibit structurally related methyltransferases or other enzymes in the NAD+ biosynthesis pathway, including NAMPT and SIRT1
"Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis" (PDF)